Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiation.
Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiation. Proc Natl Acad Sci U S A. 2018 02 13; 115(7):1582-1587.